Differential Effect of Ticagrelor Versus Prasugrel on the Adenosine-induced Coronary Vasodilatory Responses in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
Phase of Trial: Phase IV
Latest Information Update: 22 Jan 2013
At a glance
- Drugs Ticagrelor (Primary) ; Prasugrel
- Indications Acute coronary syndromes; Thrombosis
- Focus Pharmacodynamics
- 22 Jan 2013 Actual initiation date changed from Jun 2012 to Sep 2012 as reported by ClinicalTrials.gov.
- 23 Jul 2012 New trial record